InvestorsHub Logo
Followers 62
Posts 2098
Boards Moderated 0
Alias Born 05/09/2020

Re: Chuckles759 post# 81870

Tuesday, 06/02/2020 9:39:31 PM

Tuesday, June 02, 2020 9:39:31 PM

Post# of 232185
I dug up the royalty details in an 8-K filing....

....
The Asset Purchase Agreement provides for the following additional payments and royalties: (i) $1,500,000 at the time of the first dosing in a US Phase III trial or non-US equivalent; (ii) $5,000,000 at the time of the first US new drug application approval by the FDA or other non-US approval for the sale of PRO 140; and (iii) royalty payments of five percent (5%) on net sales during the period beginning on the date of the first commercial sale of PRO 140 until the later of (a) the expiration of the last to expire patent included in the acquired assets, and (b) 10 years following the first commercial sale of PRO 140, in each case determined on a country-by-country basis.
....

Form 8-K dated 16 Oct 2012

Let the lawyers fight over those table scraps....

Important IH Features

Ignore a user
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52979589

A free user can send Private Messages
Non-subscribers can send PMs during Happy Hour on Fridays from 400pm and 500pm Eastern.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News